Navidea Biopharmaceuticals Inc (NAVB)

$0.00 0.00 (-66.67%)
Market Cap 20,000.00
Revenue (ttm) 70,000.00
Net Income (ttm) -15.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -21,685.71%
Debt to Equity Ratio 0.00
Volume 155,000
Avg Vol 7,160
Day's Range N/A - N/A
Shares Out 100.08M
Stochastic %K 20%
Beta 2.04
Analysts Strong Buy
Price Target $5.00

Latest News on NAVB

No data available.